Cargando…

Covid-19 vaccination, adverse events, and detection of antibodies

Detalles Bibliográficos
Autores principales:	Kristensen, Søren Risom, Nybo, Jette, Hansen, Annebirthe Bo, Ernstsen, Siw Leiknes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Letter to the Editors-in-Chief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493642/ https://www.ncbi.nlm.nih.gov/pubmed/34628228 http://dx.doi.org/10.1016/j.thromres.2021.09.020

Ejemplares similares

Reply to a letter from Jackson J et al: Effect of pH on thrombin activity measured by calibrated automated thrombinography
por: Kristensen, Søren Risom, et al.
Publicado: (2020)

Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Correspondence
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

A sensitive tissue factor activity assay determined by an optimized thrombin generation method
por: Kristensen, Søren Risom, et al.
Publicado: (2023)

Thromboembolic events related to atrial fibrillation during the COVID-19 epidemic in Denmark
por: Rasmussen, Peter Vibe, et al.
Publicado: (2020)

Detection of anti-GPIbα autoantibodies in a case of immune thrombocytopenia following COVID-19 vaccination
por: Nakamura, Takayuki, et al.
Publicado: (2022)

Early thromboembolic events in hospitalized COVID-19 patients
por: Rosen, Raphael J.
Publicado: (2020)

Preexisting anti-PF4 antibodies are not further triggered upon vaccination with SARS-CoV-2 vector vaccines in a cohort of 400 health care workers
por: Angelika, Wagner, et al.
Publicado: (2022)

The effect of race on composite thrombotic events in patients with COVID-19
por: Esenwa, Charles, et al.
Publicado: (2021)

Delayed catastrophic thrombotic events in post-acute COVID-19
por: Gupta, Abhinav, et al.
Publicado: (2022)

The effect of pH on thrombin generation–An unrecognized potential source of variation
por: Kristensen, Søren Risom, et al.
Publicado: (2020)

Thrombin generation measured on ST Genesia, a new platform in the coagulation routine lab: Assessment of analytical and between‐subject variation
por: Kristensen, Søren Risom, et al.
Publicado: (2022)

Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?
por: Zuin, Marco, et al.
Publicado: (2021)

Fatal intracranial hemorrhage in patient with thrombocytopenia and positive HIT antibodies after vaccination with ChAdOx1 nCoV-19 - VITT without thrombosis?
por: Medić, Marijana Grgić, et al.
Publicado: (2022)

Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?
por: Siguret, Virginie, et al.
Publicado: (2020)

Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination
por: Franchini, Massimo, et al.
Publicado: (2021)

Incidence of venous thromboembolic events in COVID-19 patients after hospital discharge: A systematic review and meta-analysis
por: Zuin, Marco, et al.
Publicado: (2022)

Thrombosis post COVID-19 vaccinations: Potential link to ACE pathways
por: Dalan, Rinkoo, et al.
Publicado: (2021)

Vaccine-induced immune thrombotic thrombocytopenia after the BNT162b2 mRNA Covid-19 vaccine: A case study
por: Rodríguez, Carmen, et al.
Publicado: (2021)

Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study
por: Godon, Alexandre, et al.
Publicado: (2021)

Safety of COVID-19 vaccination in patients with previous cerebral venous sinus thrombosis
por: Gil-Díaz, Aída, et al.
Publicado: (2022)

Vaccine-induced immune thrombocytopenia and thrombosis after mRNA-1273 booster vaccination
por: Langerak, T., et al.
Publicado: (2022)

Circulating immune cells with megakaryocyte signature in response to COVID-19 mRNA vaccination
por: Kanaji, Taisuke, et al.
Publicado: (2022)

Major cardiovascular events in patients with Coronavirus Disease 2019: Experience of a cardiovascular department of Northern Italy()
por: Bellosta, Raffaello, et al.
Publicado: (2021)

No evidence of increased rate of thrombotic recurrences in patients with history of venous thromboembolism after vaccination for COVID-19
por: Porfidia, Angelo, et al.
Publicado: (2022)

Comparison of IMPROVE, modified IMPROVE, IMPROVEDD, Padua and CHA2DS2-VASC risk scores for venous and arterial thrombotic events prediction in hospitalized COVID-19 patients
por: Lucijanic, Marko, et al.
Publicado: (2022)

SARS-CoV-2 infection, vaccination and acquired hemophilia: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

SARS-CoV-2 infection, vaccination and acquired hemophilia: Reply
por: Franchini, Massimo, et al.
Publicado: (2023)

Is pulmonary embolism occurring after SARS COV-2 vaccination provoked or unprovoked?
por: Catella, Judith, et al.
Publicado: (2022)

Association of anticoagulation use with SARS-CoV2 detection()
por: Kavecansky, Juraj, et al.
Publicado: (2021)

Immune Thrombotic Thrombocytopenic Purpura following Pfizer-BioNTech anti-COVID-19 vaccination in a patient healed from lymphoma after allogeneic hematopoietic stem cell transplantation
por: Innao, Vanessa, et al.
Publicado: (2022)

Double high-dose immunoglobulin for ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia()
por: Huang, Ching-Tai, et al.
Publicado: (2021)

Association between SARS-CoV-2 infection or vaccination and acquired hemophilia A: A case report and literature update
por: Franchini, Massimo, et al.
Publicado: (2023)

Four cases of acquired hemophilia A following immunization with mRNA BNT162b2 SARS-CoV-2 vaccine
por: Leone, Maria Cristina, et al.
Publicado: (2022)

Effect of government interventions to contain the COVID-19 pandemic on incidence of pulmonary embolism - A Danish nationwide register-based cohort study
por: Sindet-Pedersen, Caroline, et al.
Publicado: (2021)

COVID-19 associated pulmonary thrombosis
por: van Nieuwkoop, C.
Publicado: (2020)

Therapeutic anticoagulation in COVID-19 patients
por: Belfaqeeh, O., et al.
Publicado: (2021)

When to use anticoagulation in COVID-19()()
por: Moll, Matthew, et al.
Publicado: (2021)

Therapeutic anticoagulation in COVID-19 patients
por: Lemos, Anna Cristina Bertoldi, et al.
Publicado: (2021)

Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19?
por: Nielsen, Nathan D., et al.
Publicado: (2022)

The long haul COVID-19 arterial thrombosis
por: Borrelli, Maria Pia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_asjmo6hkqrgtioi8edvdr4gp8k